预防性应用头孢曲松钠对肝硬化上消化道出血患者感染的影响*

doi:10.3969/j.issn.1672-5069.2017.03.030

Abstract

Yang Xingping, Chen Heping. Prophylactic application of ceftriaxone sodium in treatment of patients with liver cirrhosis complicated by upper gastrointestinal bleeding[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 362-363.

References

[1] 周章,宋俊,阮云丹. 肝炎肝硬化患者术中两种麻醉方式对肝肾功能及免疫指标的影响. 海南医学院学报,2016,22(15):1752-1754,1757.
[2] 李敏然,徐小元,Li MR,等. 肝硬化门静脉高压食管胃静脉曲张出血的防治研究. 中华肝脏病杂志,2015,23(4):247-249.
[3] Angeli P,Lenz K,Ginès P,et al.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis. J Hepatol,2010,53(3):397-417.
[4] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ.
[5] 梁文京,符应田,黎燕锋,等. 内镜下套扎联合药物注射治疗肝硬化合并上消化道出血的疗效. 实用医学杂志,2016,32(12): 2017-2019.
[6] Lleo A,Invernizzi P,Gershwin M E,et al.Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol,2014,32(5):615-625.
[7] Hézode C,Fontaine H,Dorival C,et al.Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology,2014,147(1):132-142.
[8] Cerini F,Gonzalez J M,Torres F,et al.Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study. Hepatology,2015,62(2):575-583.
[9] Jalan R,Fernandez J,Wiest R,et al.Bacterial infections in cirrhosis:A position statement based on the EASL Special Conference 2013. J Hepatol,2014,60(6):1310-1324.
[10] Su L,Huang Z,Wang M,et al.Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis. J Critical Care,2015,30(4):732-738.
[11] 石瑞春,杨志伟,杨理华,等. 不同抗菌药物治疗肝硬化上消化道出血感染患者的有效性与安全性评价. 中华医院感染学杂志,2015,25(24):5642-5644.
[12] 杨生义,乔惠霞,李维,等. 预防性使用抗菌药物对肝硬化合并上消化道出血患者的影响. 肝脏,2015,20(2):132-134.
[13] 张蕾,王勇,李华龙,等. 乙型肝炎肝硬化伴上消化道出血患者医院感染因素分析. 中华医院感染学杂志,2016,26(17):3903-3905.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[6]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[7]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[8]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[11]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[12]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[13]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[14]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[15]	Gao Qingbao, Li Wengang, Lin Mingqiang, et al. Efficacy of endoscopic retrograde cholangiopancreatography for the treatment of patients with acute obstructive suppurative cholangitis [J]. Journal of Practical Hepatology, 2019, 22(5): 740-743.

Prophylactic application of ceftriaxone sodium in treatment of patients with liver cirrhosis complicated by upper gastrointestinal bleeding

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments